Pyrazole derivative

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/4439 (2006.01) A61K 31/4545 (2006.01) A61K 31/496 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61K 31/541 (2006.01) A61K 31/551 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) C07D 403/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2515119

A potent antiplatelet aggregation agent which inhibits neither COX-1 nor COX- 2. It is a compound represented by the following general formula (I): (I) or general formula (II): (II) a salt of the compound, or a solvate of either. Also provided are: a medicine containing the compound, salt, or solvate; and a preventive and/or therapeutic agent for ischemic diseases which contains the compound, salt, or solvate

L'invention concerne un puissant agent d'agrégation antiplaquettaire inhibant ni COX-1 ni COX-2. Il s'agit d'un composé représenté par la formule générale suivante (I) ou formule générale (II), d'un sel dudit composé ou d'un solvate de l'un ou l'autre. Cette invention concerne également un médicament, contenant ledit composé, sel ou solvate, ainsi qu'un agent prophylactique et/ou thérapeutique contre les maladies ischémiques, lequel agent contient ledit composé, sel ou solvate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1706320

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.